ANIXA BIOSCIENCES, INC. Litigation Settlement, Expense
ANIXA BIOSCIENCES, INC. (ANIX) reported Litigation Settlement, Expense of $210.00 thousand for the 12-month period ending 2023-10-31, per its 10-K filed 2024-01-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2024-01-16
- ANIXA BIOSCIENCES, INC. litigation settlement, expense for the quarter ending 2023-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. litigation settlement, expense for the quarter ending 2023-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. litigation settlement, expense for fiscal 2023 was $210.00K.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 12 month |
|---|---|---|---|---|
| 2023-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | $0.00 derived: sum of 2 quarters · filed 2024-01-16 | $210.00K 10-K · filed 2024-01-16 | |
| 2023-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-09-06 | $210.00K 10-Q · filed 2023-09-06 | ||
| 2023-04-30 | $210.00K 10-Q · filed 2023-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |